FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars – CancerNetwork

The most common adverse reactions with Stoboclo were back pain, pain in extremity, hypercholesterolemia, musculoskeletal pain, and cystitis …
Source: back pain